Vertex Pharmaceuticals (Belgium) SRL
13.2 FTEVertex Pharmaceuticals (Belgium) reported revenue of €88.9m for the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026), with 13.2 full-time equivalents.
By total assets for 2025, Vertex Pharmaceuticals (Belgium) ranks among the 50 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Vertex Pharmaceuticals (Belgium) shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +112 % Total assets +89 % Headcount (avg FTE) +42 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vertex Pharmaceuticals (Belgium)'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 20 May 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 11 Oct 2023
Vertex Pharmaceuticals (Belgium)'s financial analysis
- Solvency4.1%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vertex Pharmaceuticals (Belgium)
3 active director(s) in the register.
Vertex Pharmaceuticals (Belgium)'s shareholders and holdings →Vertex Pharmaceuticals (Belgium)'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0781.749.031
- VAT number
- BE0781749031
- Peppol
- Registered · 0208:0781749031 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Feb 2022
- Registered office
- 1000 Brussels
- Size
- Small · 13.2 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Vertex Pharmaceuticals (Belgium) (SRL) has been based in Brussels since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €88.9m, a net profit of €1.59m and equity of €3.43m. With 13.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 4.1%, below the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vertex Pharmaceuticals (Belgium)
Companies in the same business, of comparable size and area, outside its group.
- Gilead Sciences Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €68.7m
- Menarini Benelux Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €48.6m
- sandoz Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €55.3m
- O&M Halyard Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.9m
- Novartis Pharma Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €168.8m
- SERB Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €159.3m
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- B. Braun Medical Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €22.6m
Frequently asked questions about Vertex Pharmaceuticals (Belgium)
What is the revenue of Vertex Pharmaceuticals (Belgium)?
According to the 2025 annual accounts filed with the NBB, the revenue of Vertex Pharmaceuticals (Belgium) amounts to 88,909,868 €.
What is the VAT number of Vertex Pharmaceuticals (Belgium)?
In Belgium, the VAT number is the company number prefixed with BE: BE0781749031 for Vertex Pharmaceuticals (Belgium), if the company is VAT-registered. Its company number (CBE) is 0781.749.031.
Where is the registered office of Vertex Pharmaceuticals (Belgium)?
According to the CBE register, the registered office of Vertex Pharmaceuticals (Belgium) is in 1000 Brussels.
What is the equity of Vertex Pharmaceuticals (Belgium)?
At the close of the 2025 financial year, the equity of Vertex Pharmaceuticals (Belgium) amounts to 3,434,963 €, a solvency of 4.1% of total assets.
How many people work at Vertex Pharmaceuticals (Belgium)?
13.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vertex Pharmaceuticals (Belgium)?
The register lists 3 active mandates at Vertex Pharmaceuticals (Belgium). Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Vertex Pharmaceuticals (Belgium) within its sector?
By total assets for 2025, Vertex Pharmaceuticals (Belgium) ranks among the 50 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Vertex Pharmaceuticals (Belgium)
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →